Covered recipient · General Payments record
RICHARD W SCHAFER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$9,427.50
- Reported across 315 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,218.99 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $328.31 | 19 |
| Janssen Pharmaceuticals, Inc | $180.48 | 2 |
| Lilly USA, LLC | $172.10 | 5 |
| Novo Nordisk AS | $121.83 | 1 |
| GlaxoSmithKline, LLC. | $114.42 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $111.85 | 1 |
| Astellas Pharma US Inc | $64.36 | 2 |
| Acerta Pharma LLC | $59.21 | 3 |
| Lundbeck LLC | $46.06 | 2 |
| Medtronic, Inc. | $20.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.61 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030458 | CMS |
| ABBVIE INC. | $10.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030460 | CMS |
| ABBVIE INC. | $10.80 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030462 | CMS |
| ABBVIE INC. | $14.61 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030464 | CMS |
| ABBVIE INC. | $24.92 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030466 | CMS |
| ABBVIE INC. | $4.22 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030468 | CMS |
| ABBVIE INC. | $114.41 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030470 | CMS |
| ABBVIE INC. | $16.70 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030472 | CMS |
| ABBVIE INC. | $15.50 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030474 | CMS |
| ABBVIE INC. | $5.67 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030476 | CMS |
| ABBVIE INC. | $5.97 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030478 | CMS |
| ABBVIE INC. | $9.36 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030480 | CMS |
| ABBVIE INC. | $18.52 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030482 | CMS |
| ABBVIE INC. | $16.70 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030484 | CMS |
| ABBVIE INC. | $7.15 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030486 | CMS |
| ABBVIE INC. | $7.06 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030488 | CMS |
| ABBVIE INC. | $16.28 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030490 | CMS |
| ABBVIE INC. | $8.35 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030492 | CMS |
| ABBVIE INC. | $7.06 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030494 | CMS |
| Astellas Pharma US Inc | $32.98 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139291822 | CMS |
| Astellas Pharma US Inc | $31.38 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139362865 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.80 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105587272 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.54 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105839001 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.87 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105829669 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $111.85 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117897182 | CMS |
| GlaxoSmithKline, LLC. | $114.42 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116342090 | CMS |
| Janssen Pharmaceuticals, Inc | $65.06 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078137327 | CMS |
| Janssen Pharmaceuticals, Inc | $115.42 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078137329 | CMS |
| Lilly USA, LLC | $5.74 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135389529 | CMS |
| Lilly USA, LLC | $22.04 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135389527 | CMS |
| Lilly USA, LLC | $9.43 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135335176 | CMS |
| Lilly USA, LLC | $121.81 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135366164 | CMS |
| Lilly USA, LLC | $13.08 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135366162 | CMS |
| Lundbeck LLC | $28.06 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145966100 | CMS |
| Lundbeck LLC | $18.00 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145966102 | CMS |
| Medtronic, Inc. | $20.37 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117172043 | CMS |
| Novo Nordisk Inc | $121.83 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097612659 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.